Lopinavir/ritonavir use in Covid-19 infection: is it completely non-beneficial?
This article points out some of those important lessons with some suggestions for future clinical trials.
PMID: 32474026 [PubMed - as supplied by publisher]
Source: Journal of Microbiology, Immunology, and Infection - Category: Microbiology Authors: Owa AB, Owa OT Tags: J Microbiol Immunol Infect Source Type: research
More News: Allergy & Immunology | Clinical Trials | Coronavirus | COVID-19 | Intensive Care | Kaletra | Learning | Lessons | Microbiology | Norvir | SARS | Statistics | Study